Guidance for exceptional importation and sale of medical devices

This document does not constitute part of the Food and Drugs Act (the Act) or its regulations. In the event of any inconsistency or conflict between the Act or regulations and this document, the Act or the regulations take precedence. This document is an administrative document that is intended to facilitate compliance by the regulated party with the Act, the regulations and the applicable administrative policies.

On this page

About this guide

This guidance document supports new amendments made to sections 62.27 to 62.32 of the Medical Devices Regulations (Regulations). The amendments give Health Canada the regulatory tools needed to allow the exceptional importation and sale of medical devices, in order to help track, prevent and mitigate shortages.

The amendments to the Regulations come into effect on March 2, 2022.

Who this guide is for

This guidance document will help importers, distributors, manufacturers and other establishment licence holders understand their regulatory requirements for the exceptional importation of medical devices. It is directed to:

Under the regulatory requirements, licence holders are required to:

The exceptional importation framework

The exceptional importation framework makes it possible to address medical device shortages (actual or anticipated). It permits the exceptional importation and sale of devices that do not fully meet Canadian regulatory requirements, but that are manufactured to comparable quality standards.

A medical device shortage occurs when a manufacturer of a medical device is unable to meet Canadian market demand for the device or its components, accessories or parts.

Health Canada publishes verified medical device shortages on the Medical device shortages: List of shortages.For more information about regulatory requirements for shortage reporting, please consult the Guidance for reporting medical device shortages and discontinuations.

For a medical device to be authorized, establishment licence holders must meet the conditions under section 62.29. Devices that are authorized for exceptional importation and sale are known as "designated medical devices". They are included in the List of medical devices for exceptional importation and sale. Health Canada amends this list as required in accordance with section 62.28 of the Regulations, when available information indicates that:

In addition, the designated device must be authorized in another jurisdiction or must meet with the applicable legal requirements within its jurisdiction.

Under section 62.3, certain provisions of the Regulations do not apply to medical devices brought to Canada by exceptional importation. These include sections 21 to 21.2 and 26, which cover labelling and device licence requirements.

Under section 62.31(1), designated medical devices are subject to provisions of the Regulations covering establishment licences, maintaining distribution records, complaint handling, conducting a recall or reporting incidents and any shortage to Health Canada. These provisions are described in sections 44 to 62.2 and sections 62.32 to 65.1. Importers, distributors and manufacturers seeking to import or sell designated medical devices in Canada must hold a valid medical device establishment licence (MDEL).

How to submit an application

An establishment that holds an active MDEL may ask Health Canada to add a medical device to the List of medical devices for exceptional importation and sale when there is a known or expected shortage.

To do so, complete the following form and submit it to Health Canada at md-exceptional.import.sale-import.vent.exceptionnellei-im@hc-sc.gc.ca.

Health Canada may also add a medical device to the list without having received an application.

Notification

Establishments must notify Health Canada at least 5 business days before the day on which a designated device is imported (consult section 62.29(a) of the Regulations). This notification is required for each shipment, and must include information on the establishment and designated device.

Failure to notify Health Canada within this timeframe may lead to compliance and enforcement actions.

Health Canada undertakes compliance and enforcement activities in accordance with the Compliance and enforcement policy for health products (POL-0001). This policy describes our compliance and enforcement approach for all health products regulated under the Food and Drugs Act and its regulations.

Compliance and enforcement actions are based on risk and the level of non-compliance. Actions may include removing the approved designated device from the List for exceptional import and sale.

To provide notification of the pending importation of a designated device, complete and submit the following information to Health Canada at md-exceptional.import.sale-import.vent.exceptionnellei-im@hc-sc.gc.ca:

Required information

When notifying Health Canada, an establishment must provide the following information (refer to Section 62.29(a) of the Medical Devices Regulations):